Category: News

December 2023 –England & Company is pleased to announce the closing of several strategic and financial transactions for Extremity Medical, LLC in 2023. Extremity Medical is an orthopedic medical device company specializing in extremity implants known for improved outcomes, especially in patients with poor bone quality. Based in Parsippany, NJ, Extremity Medical develops and markets proprietary, next-generation products to address fixation, fusion and motion preservation in procedures in the lower and upper extremities, including the foot & ankle, hand, and wrist. It is one of the largest privately held independent companies in the U.S. serving the foot & ankle market.

Extremity Medical has entered into a strategic relationship with Henry Schein, Inc. (NASDAQ: HSIC), a leading FORTUNE 500 global healthcare products and solutions company, and a new entrant into the orthopedic extremities market. The relationship is part of Henry Schein’s expansion in orthopedics and complementary to Schein’s pending acquisition of TriMed, Inc. For more information about Schein’s expansion, please see this link.

Matthew Lyons, Extremity’s Chairman and Chief Executive Officer, said, “We are very excited to be working with Henry Schein in its build up in orthopedic extremities. They will bring significant complementary products and sales channels with TriMed. It’s a perfect fit between Extremity’s full portfolio of innovative lower extremity products and wrist replacement and TriMed’s leading portfolio of upper extremity products.” Lyons added “The England team did a great job identifying this creative opportunity, leading the negotiations and bringing the transaction to the finish line.”

England also closed a total of $21 million in convertible note and working capital financings for Extremity Medical between June and November of this year. Extremity Medical will use the new capital provided by its latest financing to invest in the growth of its business and refinance existing debt. Lyons said “The England team was instrumental in securing us innovative growth and working capital financing solutions in a challenging environment.”

Extremity Medical’s innovative product portfolio includes advanced implant systems for addressing Charcot neuropathy in diabetic patients, as well as less-invasive surgical implants to correct common foot deformities, and address trauma and arthritis. Extremity Medical also offers a revolutionary total wrist replacement to restore more natural wrist motion in arthritic patients.

September 2023 –  England & Company is pleased to announce that it served as exclusive financial advisor to Inertia Engineering and Machine Works, Inc. (“Inertia”) in its sale to MacLean Power, LLC (“MPS”). Inertia, based in Stockton, California, is a manufacturer of highly advanced switchgear and automation equipment for the utility market. For over 25 years, Inertia’s products have been installed by utilities across the United States and internationally, providing key functionality in power distribution and transmission.

“We are thrilled to have worked with England & Company on this transaction; they went above and beyond for us,” said Megan Rowe, President of Inertia. “England & Company’s in-depth knowledge of the utility market, including its ability to properly position Inertia’s products and technical capabilities with potential buyers and valuable hands-on strategic advice during the transaction process, ensured that our company found the best possible partner for Inertia’s next stage of growth.”

The acquisition of Inertia extends MPS’ existing product portfolio into advanced overhead switchgear technology sold to utility customers.

About Inertia Engineering & Machine Works

Inertia Engineering and Machine works, Inc. is a global leader in the manufacturing of high quality, overhead, medium voltage switchgear, automation products, and specialized equipment used in electric utility and grid automation ‘Smart Grid’ applications. Learn more at www.inertiaworks.com.

About MacLean Power Systems

MacLean Power Systems is a leading manufacturer of engineered products used in the maintenance, repair, upgrade, and construction of transmission, distribution, substation, and communications infrastructure. Learn more at www.macleanpower.com.

October 2023 – England & Company is pleased to announce that it recently served as exclusive financial advisor to Encycle Corporation (“Encycle”) in its sale to Instone Capital Partners. Encycle, based in San Marcos, California, is a data-driven technology company focused on helping commercial businesses dramatically improve the efficiency of their HVAC systems using IoT-enabled services. The acquisition will ensure that Encycle has the resources to accelerate the growth and expansion of the company and its multi-patented, AI-enhanced Swarm Logic® energy management solutions.

“I look forward to helping the Encycle team continue to build an organization as an industry leader that creates technologies to solve sustainability, decarbonization, and building management goals,” Lisa Varga, Encycle Executive Advisor explained and added, “I also look forward to engaging the industry once again to help make an impact on many levels.”

Encycle’s Swarm Logic solutions provide enterprise-wide portfolios of buildings with automated HVAC energy efficiency and fault detection for predictive asset maintenance, significant energy cost savings, and decarbonization.

About Encycle
Encycle is a data-driven technology company that is transforming energy management for multi-site commercial and industrial companies. The company leverages the power of artificial intelligence in its patented cloud-based technology to lower its clients’ electric costs, maximize energy efficiency, and reduce environmental impact. Companies using Swarm Logic^® routinely reduce HVAC electric costs and consumption by 10%-30% with little or no capital investment. For more information about Encycle, visit www.encycle.com.

About Instone Capital Partners:
Instone Capital Partners is a family-owned and operated investment company focused on working with cutting-edge solutions providers and industry-leading businesses committed to sustainability and decarbonization through innovation and energy efficiency.

August 2023 – England & Company is pleased to announce that it recently served as exclusive placement agent in Flume, Inc.’s (“Flume”) recent growth financing provided by HCAP Partners, a California-based private equity firm and nationally recognized impact investor.

Flume, based in San Luis Obispo, CA, is making significant contributions toward conservation and sustainability as the best-in-class provider of high-definition water data and analytics to consumers, the water technology industry, and the water resource management ecosystem.  This funding will enable Flume to expand its operations, customer base, and corresponding market share through working capital and geographical expansion.

“We were fortunate to have the guidance and support of England & in securing essential funding to achieve our mission.  We had the England team’s full support throughout the process, top to bottom.  This funding will enable us to expand our business and reach new heights. As CEO, I am delighted to continue pushing the boundaries of innovation and introducing new solutions for our customers, as well as utilities and government stakeholders,” expressed Ric Miles, CEO of Flume.

Flume brings unprecedented insights into residential water use to both homeowners and water utilities. Using Flume, homeowners can save water through 24/7 water monitoring for indoor and outdoor water consumption, customizable leak detection, detailed breakdowns and insights into individual water appliances, and suggested water budgets. With a simple installation process requiring no plumbers or pipe cutting, Flume provides the in-depth water use details and control functionality necessary to mitigate issues before they result in high water bills or costly damages.

About Flume

Inspired by California’s record drought, Flume empowers homeowners to understand their use better and conserve water. By providing real-time water use information, Flume protects the home, puts the power of water consumption and conservation in the customer’s hands, and improves the relationship with our most precious resource. The Flume® Smart Water System consists of an easy-to-install sensor that adapts to most existing home water meters, communicating water use to the homeowner in real-time. To date, Flume has tens of thousands of devices installed across the United States. Flume bridges the gap between consumers and water providers to fundamentally change how we understand and access water data.

About HCAP Partners

HCAP Partners is a diversely owned private equity firm specializing in providing mezzanine debt and private equity for underserved, lower-middle market companies throughout California and the Western United States. The firm seeks to invest $3 million to $25 million in established businesses generating between $10 million and $100 million in revenues in the healthcare, software, services, and manufacturing industries.

August 2023 – England Securities is pleased to announce that it served as exclusive financial advisor to EI Electronics LLC (“Electro Industries/GaugeTech”) in its sale to Hubbell Power Systems, Inc. (“HPS”), a subsidiary of Hubbell Incorporated (NYSE: HUBB).

Electro Industries/GaugeTech, based in Westbury, New York, provides advanced energy management systems and power meters that leverage predictive analytics, cloud services, and artificial intelligence for utility and commercial and industrial customers.

For over 45 years, Electro Industries/GaugeTech has led the way in energy management and power monitoring. They offer comprehensive energy management solutions that incorporate cutting-edge metering technology and AI-powered energy management.

About HPS

HPS, headquartered in Columbia, South Carolina, operates manufacturing facilities in the United States and around the world. HPS is a subsidiary of Hubbell Incorporated and an international manufacturer of quality transmission, distribution, substation, OEM, and telecommunications products for a broad range of non-residential and residential construction and electric, gas, and water utility applications.

October 2022 – England Securities is pleased to announce that it recently served as the exclusive financial advisor to Hayward Gordon L.P. (“Hayward Gordon”) in its sale to EBARA Corporation Japan (“Ebara”).

Based in Halton Hills, ON, Canada, Hayward Gordon supplies a comprehensive line of pumps and mixers to a variety of end markets, including water and wastewater, mining, general industrial, and industrial sanitary. The acquisition is expected to expand Hayward Gordon’s reach and leverage EBARA’s product portfolio and manufacturing expertise.

“We are delighted to join EBARA, whose values closely align with Hayward Gordon in how we serve our customers, provide opportunities for our people, and our commitment to innovation,” said John Hayward of Hayward Gordon.

Prior to the sale, Hayward Gordon was a portfolio company of Element Partners, a private equity firm dedicated to investments in sustainability technology and innovation in large industrial markets.

“We are very pleased to have partnered with England & Company for this transaction,” said Michael Bevan, General Partner of Element Partners.  “England’s team was key in helping Hayward Gordon find the right partner, negotiating the terms of deal, and closing the transaction.”

About Hayward Gordon

Hayward Gordon encompasses three industry-leading brands in the pump and mixer market: Hayward Gordon, Sharpe Mixers, and Scott Turbon Mixer. The Company is a leader in solids handling pumps for water and wastewater treatment and offers one of the broadest lines of industrial and sanitary mixers in North America. Hayward Gordon operates facilities in Halton Hills, ON, Canada and Adelanto, CA, USA.

About Ebara Corporation

Headquartered in Tokyo, Japan, with more than 17,000 employees around the World, EBARA Corporation is one of the world’s leading producers of pumps, compressors, fans, gas turbines, chillers, and semiconductor equipment for the industrial, energy, infrastructure, and environmental sectors.

October 2022 – England Securities served as the exclusive placement agent to Ossio Ltd. (“Ossio”), a rapidly growing orthopedic fixation technology company, in its $38.5 million Series C financing. This financing, which was led by MVM Partners (“MVM”), a Boston- and London-based growth equity firm, represents England’s 9th transaction in orthopedics, and 5th transaction specifically in foot & ankle orthopedics.

Ossio, based in Woburn, MA and Caesarea, Israel, produces orthopedic implants made with OSSIOfiber® Intelligent Bone Regeneration Technology, a breakthrough in fixation material that provides the first credible solution to the shortcomings of permanent metal hardware, conventional resorbable, and allograft implants. The technology provides unparalleled mechanical strength and natural bone healing in a non-permanent implant.

“We are delighted to have secured this level of interest and commitment from such an experienced and distinguished medical technology investment firm,” said OSSIO’s Chief Executive Officer, Brian Verrier. “England’s Healthcare Investment Banking team was instrumental in helping us secure an ideal lead investor with relevant orthopedic experience and a focus on companies of our stage.”

“We believe that OSSIO’s novel bio-integrative technology has the potential to transform the orthopedic fixation market,” said MVM’s founding Partner, Dr. Stephen Reeders. “We are excited to support the company’s mission to improve patient outcomes across a broad range of procedures.” Dr. Reeders and his MVM colleague, Dr. Kevin Cheng, join OSSIO’s board of directors as part of this financing.

Verrier continued, “The additional funding will enable us to accelerate further adoption of OSSIOfiber Intelligent Bone Regeneration Technology by orthopedic and podiatric surgeons in the United States. Specifically, we intend to use these funds to fortify new product development, sales force expansion, patient outreach, and medical education.”

Made from a proprietary mineral fiber matrix held together by a naturally degradable polymer, the material is biointegrative (replaced by natural bone over time). It provides surgeons a more biologically friendly way to restore patient stability and mobility while leaving nothing permanent behind. More than 10,000 OSSIOfiber implants have been used in orthopedic surgeries since their commercial introduction in 2019.

About OSSIO

OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians and payors. Founded in 2014, its vision is to provide the first credible replacement to metal implants in the multibillion-dollar global orthopedic fixation market with its OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO’s development headquarters is located in Caesarea, Israel, and its U.S. headquarters is in Woburn, MA.

About MVM Partners

MVM has invested in high-growth healthcare businesses since 1997. The firm has a broad, global investment outlook spanning medical technology, pharmaceuticals, diagnostics, digital health, and other sectors of healthcare.